Aurora Cannabis Inc (ACB): Next-Year EPS Estimate 161.79%
As of 2026-09-25, Aurora Cannabis Inc (ACB) has a next-year EPS growth estimate of 161.79%. Featured in 4 EPS revision reports, most recently on 2026-08-17.
On 2026-08-19, analyst consensus for ACB's next-year EPS growth shifted from 161.75% to 161.79% — a positive change of 0.04 percentage points. The revised estimate has been sustained across 34 subsequent trading sessions. Current-year growth is projected at 86.25%.
What's Driving This
Aurora Cannabis has risen primarily after analysts sharply raised its next-year EPS growth estimate on 2026-08-07, from 107.53% to 161.30
Generated 2026-09-14 from news as of 2026-09-14
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 161.79%
- EPS growth this year
- 86.25%
- EPS next quarter (est)
- -$0.05
- Last price
- $4.10
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-25 | 161.79% | 86.25% | -$0.05 | $4.10 |
| 2026-09-24 | 161.79% | 86.25% | -$0.05 | $4.16 |
| 2026-09-23 | 161.79% | 86.25% | -$0.05 | $4.22 |
| 2026-09-22 | 161.79% | 86.25% | -$0.05 | $4.27 |
| 2026-09-21 | 161.79% | 86.25% | -$0.05 | $4.03 |
| 2026-09-20 | 161.79% | 86.25% | -$0.05 | $3.87 |
| 2026-09-18 | 161.79% | 86.25% | -$0.05 | $3.87 |
| 2026-09-17 | 161.79% | 86.25% | -$0.05 | $3.85 |
| 2026-09-16 | 161.79% | 86.25% | -$0.05 | $3.83 |
| 2026-09-15 | 161.79% | 86.25% | -$0.05 | $3.82 |
| 2026-09-14 | 161.79% | 86.25% | -$0.05 | $3.81 |
| 2026-09-13 | 161.79% | 86.25% | -$0.05 | $3.74 |
| 2026-09-11 | 161.79% | 86.25% | -$0.05 | $3.74 |
| 2026-09-10 | 161.79% | 86.25% | -$0.05 | $3.73 |
| 2026-09-09 | 161.79% | 86.25% | -$0.05 | $3.88 |
| 2026-09-08 | 161.79% | 86.25% | -$0.05 | $3.87 |
| 2026-09-07 | 161.79% | 86.25% | -$0.05 | $3.95 |
| 2026-09-06 | 161.79% | 86.25% | -$0.05 | $3.95 |
| 2026-09-04 | 161.79% | 86.25% | -$0.05 | $3.95 |
| 2026-09-03 | 161.79% | 86.25% | -$0.05 | $3.89 |
| 2026-09-02 | 161.79% | 86.25% | -$0.05 | $4.03 |
| 2026-09-01 | 161.79% | 86.25% | -$0.05 | $4.05 |
| 2026-08-31 | 161.79% | 86.25% | -$0.05 | $4.05 |
| 2026-08-30 | 161.79% | 86.25% | -$0.05 | $4.01 |
| 2026-08-29 | 161.79% | 86.25% | -$0.05 | $4.01 |
| 2026-08-28 | 161.79% | 86.25% | -$0.05 | $4.01 |
| 2026-08-27 | 161.79% | 86.25% | -$0.05 | $4.01 |
| 2026-08-26 | 161.79% | 86.25% | -$0.05 | $4.00 |
| 2026-08-25 | 161.79% | 86.25% | -$0.05 | $4.01 |
| 2026-08-24 | 161.79% | 86.25% | -$0.05 | $3.94 |
Reports Featuring ACB
- 2026-08-17
SNDK Soars 45.9% After EPS Revision, AI Memory Boom Fuels Rally
- 2026-08-14
SHAZ Soars 53.6% on AI Capacity Surge; SNDK, ACB Rally on EPS Revisions
- 2026-08-13
SHAZ Surges 44.6% on AI Capacity Expansion; SNDK, ACB, CLMT, NYXH Follow
- 2026-08-12
SHAZ Soars 37.5% as AI Capacity Surges; Top EPS Revision Gainers
Recent News
- Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis MarketPR Newswire
- AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.PR Newswire
- Curaleaf CEO talks unsolicited offer to buy Aurora CannabisCNBC TV
- Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests Quarterly Update ReportExec Edge
- Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests Downloadable Quarterly Update ReportExec Edge
- Safari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara FacilityPR Newswire
- Aurora Cannabis Inc (ACB) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...GuruFocus.com
- Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹PR Newswire
Screen Performance
Aggregate stats across all 2051 tickers our top-EPS-revision screen has flagged over the past 177 days.
- Median return since detection
- +0.0%
- % of tickers in the green
- 50%
- Median return on winners
- +22.6%
- Large revisions captured
- 1770
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Aurora Cannabis Inc's next-year EPS growth estimate?▾
As of 2026-09-25, Aurora Cannabis Inc (ACB) has a next-year EPS growth estimate of 161.79%, based on analyst consensus.
When was the latest EPS estimate revision for ACB?▾
The most recent revision occurred on 2026-08-19, when analysts adjusted the next-year EPS growth estimate from 161.75% to 161.79%.
What sector and industry does Aurora Cannabis Inc belong to?▾
Aurora Cannabis Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ACB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Aurora Cannabis Inc (ACB) appears here because it was detected by our daily top-EPS-revision-performer screen.